Found 5 matching trials
Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes
PHASE2This is a randomized placebo controlled study to test whether a single 14 c...
Location
University of California at San Francisco
Treatment With hOKT3gamma1(Ala-Ala) in T1DM
PHASE2This is a phase II study to examine the clinical and immunological effects ...
Location
University of California San Francisco
PsA Treatment With hOKT3ฮณ1 (Ala-Ala)
PHASE2hOKT3gamma1 (Ala-Ala) is a man-made antibody that is commonly used to preve...
Location
University of Colorado
Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes
PHASE2Anti-CD3 monoclonal antibody (a.k.a. hOKT3gamma1 \[Ala-Ala\],teplizumab, MG...
Location
The Diabetes Center at UCSF
hOKT3gamma1 (Ala-Ala) for the Prevention of Human Islet Allograft Failure
PHASE1The broad, long-term goal of this proposal is to improve the results and ap...
Location
University of Minnesota